The rise of Sildenafil initially drove a surge for major pharmaceutical companies, however recent shifts present a murky picture for shareholders. Lower-cost competitors are eating into revenue, and continued https://tamzinzwcf402457.vidublog.com/39882375/sildenafil-and-pharma-a-precarious-bet